Individual Patient Compassionate Use of GX-I7

Conditions:   Glioblastoma;   High Grade Glioma;   Recurrent Glioblastoma;   Melanoma;   Advanced Cancer Intervention:   Drug: GX-I7 Sponsor:   Genexine, Inc. Available

Source: ClinicalTrials.gov - March 2, 2020 Category: Research Source Type: clinical trials